unit state popup appropri trial human immunodefici virus vaccine hint prepared studi george r seat iii sarah e holt david merger very robin michael gross conn club armor wood kenneth h mayer clade steven frankly n hudson mckirnan ami sheen steven self susan p buchbind abt assoc inc cambridge depart epidemiology harvard school public health boston status center vivid research prevent sharp fred hutchinson cancer seattle wa biostatist universe washington pennsylvania studi addict philadelphia pa veteran affair medic laboratory new york blood ny davis aid nation institut allergic infect disease bethesda md depart environment medicine runway common brown provide ri denver co psychology illinois howard chicago il michigan ann arbor mi office san francisco ca abstract top introduce mater method result discus refer question exist whether test prevent hiv vaccine require rapid recruit recent cohort high seroincid feasible prospect cohort conduct among person risk infect nine city month rate rcid infect observe personyear py config inter ci rate vari significantly baseline eli criterion men sex male intranet drug user female woman heterosexual island enroll site rcid highest report unprotect anal intercourse particle deficit will enroll trial use crack cocaine therefore recruit enroll retain vaccine abbrev network id inject user mm efficacy candid must address biology require candid include variable rout transmits feasible concern involve identify recruit retain obtain inform consent address potent social harm index cite one common june decks move ahead phase gp import element success identify deficit percent power value effect mani per arm would need popup annual base data project goldberg est wide rang local longitude rang geography well time thu optic strategy may lead suffice size particular import join intervene follow necessary complete et al found gaybisexu report greatest interest enroll also howe proven difficult retain literature review low year number init sought identify recruit ass implement previous effort contact protocol ass instrument across make crossgroup comparison problem more earlier prior widespread use need exchange program highly active antiretrovir therapy two factor might influence highrisk infect lang use protocol differ site set critic success random clinic determine decline conduit compare include proves riskreduct counsel issue ass actor follow establish massachusetts submit pawtucket rhode island colorado city primary three pennsylvania california common parallel develop obtain institut review board approve advisor began april disclose behavior recent insert id drug intranet intramuscularli least limit value broad entry current partner infect diagnose gonorrhea syphilis chlamydia last ndor inject year five sexual partner past either pelvic inflammatory disease trichomona chancroid first episode genie her exchange money eli age older strong accord license enzymelink immunosorb assay lisa provide eight particle none excess include target sexual transmit clinic advertise conduct target outreach street corner gay bar club subject particle refer provide screen brief confident questionnaire interview train interview detail standard inquiry sociodemograph characters alcohol injectionrel admit given script hypothet ask india fourpoint libert scale particle under antibody whose specimen repeatedly reactive enzyme immunoassay confirm post western bot counsel refer care request return every month period repeat followup interview analysis loss define roport abl obtain endpoint assoc crude odd ratio inter chisquar gender static house frequency move edu attain raceethn age control compound list regrets model variable parameter survive call stratified call sum date complete visit seroconvert midpoint known seroconvers est demography behavior specify init interview assist future mortal adjust total aprilnovemb almost met major recruit friendsacquaint snowball staff flyer poster advertise agency source remained follow observe lost cum respect signifies differ unstable table cultivar edu remain view window overall show mean draw slightly method greatly group lowest inventor le equal span selfidentifi race although status source chang optic base restrict respond within seroconvers perfreport approx third smaller sample modify history cracks seroconvert fact multiple four examine state level willing trend india state probably final die nonhivrel higher ratio substantial higherthanexpect demons enable behavior diver find smoke document work suggest size rida propos intermedia design allow office screen limit product exist lessrestrict conduct intermediate allow classic approach appear tempo chang plan isoniazid prevent tuberculosis energy decline placebo death decline due drama particularly reestablish directly credit communityacquir extend viable option since despite welldesign wellconduct result noninform null likewise lower previous differ origin init nearly unchanged compare suggest treatment postexposur prophylaxi intervene yet effect trend continue monitor populations expert prophylact mention somewhat v intent reflect lack inform late establish crackcocaineus inject risk fraction make disentangl attribute various supplement condom womancontrol microbicid parent exposure urgent compete sharp contrast similar baltimore maryland montreal canada highhivpreval demons avail controversy surround effect expand access label modify combine address approach nonvaccin health hivinfect network acquire syndrome hamper intern peer zimbabwe w c mcfarland publish manuscript ii nonoxynol into home specimen collect technique remote motif expect evenhigh work support cautionary note common chang seropreval practice morbid implement example substantial decrease rel reflect hand spring alter saturn without success special introduce offer chemoprophylaxi nonoccup decrease infect increase active increase possible occur artist minor procedure process implement result admit level value along serious major rail address success acknowledge support hivnetsponsor institut servicesthrough contract nai subcontract project part genre grant mr resource ai institut team domes master contractor dr g coord flee central viral rickettsi service shipyard archer repository biome dr j left f k b situ beth israel de karla stone off mccauley z rstenberg author rate editor assist cherry mart contribute member content public necessarily view policy mention trade name commerce organ imply endorse govern note reprint request huntington avenue email gseageathsphharvardedu var u great hsphharvardedu documentgetelementbyideminnerhtml hrefmailto leaving nl virusprogress prospect engl med free full text talk bretscher pl strategy science isimedlin hasn bf scientific issue develop bolognesi dp sci marchapril said opportun novel bangla crm phillip require lancet hitman vaccineswher go nat suppl snow re hum retrovirus ein zquez regard jeff hw value termend sh fischer rd prepare partnership challenge hauled lambert j prepare ethic mediator chimney uri coat tj acquire immune desc send ar wagner l mcelrath mj prevent discrimin volume lesson cohen panel vote delay refworld paradox steel fr good bad differ green put lid time sunday magazin march fast intermediate value workshop summary sd prevail metropolitan area d ge mclellan outoftreat merlin nelson ke hlavov gala prepare wolf behavior hivseroconvers inject meyer naval almond dh page riley homosexual bisexual young men sp douglas jm dj infect di dc friedman revid decline spider abstractfre particle vp tuc present xi intern confer vanc british columbia juli ba taylor pe arrest achieve gr kh greater horsburgh cr jr immunology status epidemic heagerti read lenders wr heat rep kalbfleisch jd parentid rl failure john son peter kd kochanek murphy sl death final vital status report vol hyattsvil gordon fm matt jp miller control pain syringeexchang programm invite commentary le mostèr de monthéal bureau moth franco program area find recommend langenberg ag bulk again sf recombin glycoprotein simplex type safety immunogen intern loud wc austin alexa wj gonococc chlamydi press nguez holm contract song acquisit nairobi prostitute jama spieler critchlow vittinghoff early detect th world geneva switzerland hallan haber longing im direct indirect effect anderson rm gupta communitywid chemotherapy immunotherapi spread natur policy ja obrien stage zidovudin semen coltit prototype process receive decent accept 